Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined N-of-1 trial of mexiletine versus placebo in non-dystrophic myotonia
NL-OMON34131Phase 2Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of mexiletine, sponsored by Radboud University Medical Center. Started Jan 2014; status: recruiting.
02
Drugs
mexiletine
Beyond the preview
Go deeper on NL-OMON34131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34131.